help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on July 16, 2009, doi:10.1164/rccm.200901-0159PP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200901-0159PPv1
180/7/588    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Coxson, H. O.
Right arrow Articles by Sin, D. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coxson, H. O.
Right arrow Articles by Sin, D. D.
American Journal of Respiratory and Critical Care Medicine Vol 180. pp. 588-597, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200901-0159PP


Pulmonary Perspective

New and Current Clinical Imaging Techniques to Study Chronic Obstructive Pulmonary Disease

Harvey O. Coxson1,2,4, John Mayo2,3,4, Stephen Lam3,5, Giles Santyr6,7, Grace Parraga6,7 and Don D. Sin1,2,3

1 The Providence Heart and Lung Institute and 2 The James Hogg iCAPTURE Center, St. Paul's Hospital, Vancouver; 3 Department of Medicine and 4 Department of Radiology, The University of British Columbia, Vancouver; 5 The British Columbia Cancer Agency, Vancouver, British Columbia; 6 Imaging Research Laboratories, Robarts Research Institute, London, Ontario; and 7 Department of Medical Biophysics and Department of Medical Imaging, The University of Western Ontario, London, Ontario, Canada

Correspondence and requests for reprints should be addressed to Don D. Sin, M.D., Providence Heart and Lung Institute, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, V6Z 1Y6 Canada. E-mail: don.sin{at}hli.ubc.ca

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by both small airway and parenchymal abnormalities. There is increasing evidence to suggest that these two morphologic phenotypes, although related, may have different clinical presentations, prognosis, and therapeutic responses to medications. With the advent of novel imaging modalities, it is now possible to evaluate these two morphologic phenotypes in large clinical studies using noninvasive or minimally invasive methods such as computed tomography (CT), magnetic resonance imaging (MRI), and optical coherence tomography (OCT). In this article, we provide an overview of these imaging modalities in the context of COPD and discuss their strengths as well as their limitations for providing quantitative COPD phenotypes.

Key Words: chronic obstructive pulmonary disease • imaging • phenotype







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society